Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
Jul 27, 2026, 03:34

Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026

Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:

ISTH 2026, Paris — more than 6,800 delegates, the largest ISTH Congress in over a decade, and plenty of outstanding presentations.

One of my highlights was not in a lecture hall: it was on a small stage in the exhibition hall, in the ISTH New Frontier Forum.

Jeffrey Weitz laid out the whole case for FXI/XIa as a target:

  • Severe congenital FXI deficiency — bleeding after surgery or injury, almost none spontaneously; protection from ischaemic stroke and VTE, but not from myocardial infarction.
  • High FXI roughly doubles the risk of venous thrombosis; low FXI cuts arterial and venous events by half or more.
  • In animals, FXI inhibition blocks thrombosis without adding bleeding.
  • Dispensable for haemostasis, essential for clot propagation.

Credit to the format: 15–20 minutes, open stage, headphones, questions straight after, and microlearning modules on ISTH Academy to follow up.

No warm-up — reach the point and defend it.

More of this, please.”

Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026

Stay updated with Hemostasis Today.